Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-07

FDA Approved: ESZOPICLONE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals' supplemental application for eszopiclone (generic), a sleep medication used to treat insomnia. This action confirms approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eszopiclone (generic) (Eszopiclone)

Snippet

SUPPL AP for ESZOPICLONE (ESZOPICLONE)